Bioscience Iv Gp Ltd. F2 is 10% at Radius Health, Inc. (RDUS). They have made 1 open-market trade across 1 company since 2014, most recently 2014-06-11.
CIK 0001600632
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $4.7M since 2014, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RDUS | 587,500 | $17.6M |
Shares reported on the most recent Form 4, priced at the 2014-06-13 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RDUS | BUY | 2014-06-11 | 2014-06-13 | $8.00 | $4.7M | -33.2% | -2.6% | -2.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.